Carcinoma, Adenoid Cystic: all 102 studies

Page 1 of 2. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.

• Phase II Trial Comparing Stereotactic Body Radiotherapy Versus Active Surveillance for Oligometastatic Adenoid Cystic CarcinomaNot yet recruitingNCT07845097Phase 2
• Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate CancerRecruitingNCT07667400Phase 1/2
• Surgery Plus Postoperative Radiotherapy for T4 Sinonasal Adenoid Cystic Carcinoma: A Prospective Observational StudyRecruitingNCT07652489
• Neoadjuvant Anlotinib and Epirubicin for T4 Sinonasal Adenoid Cystic CarcinomaNot yet recruitingNCT07616141Phase 2
• SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic CarcinomaNot yet recruitingNCT07563088
• A Study of Becotatug Vedotin (MRG003) Combined With Epirubicin as Neoadjuvant Therapy for EGFR-Positive, Unresectable Recurrent Sinonasal Adenoid Cystic CarcinomaRecruitingNCT07522879Phase 2
• Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)Not yet recruitingNCT07521670Phase 2
• Epirubicin Interventional Chemotherapy for Sinonasal Adenoid Cystic Carcinoma (SNACC): A Prospective StudyRecruitingNCT07320508Phase 2
• Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)RecruitingNCT07162480Phase 2
• A Study of Enfortumab Vedotin in People With Adenoid Cystic CarcinomaRecruitingNCT06891560Phase 2
• A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-KitRecruitingNCT06805825Phase 1
• A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland CancersRecruitingNCT06805617Phase 2
• Clinical Trial of HG146 Administered to Participants With Adenoid Cystic CarcinomaRecruitingNCT06781567Phase 2
• Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic CarcinomaRecruitingNCT06118086Phase 1/2
• CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACCRecruitingNCT05774899Phase 1/2
• Simultaneous Integrated Boost in Carbon Ion Radiotherapy for Head and Neck Adenoid Cystic CarcinomaRecruitingNCT05733910Not applicable
• A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid TumorsRecruitingNCT05377996Phase 1/2
• Tyrosine Kinase Inhibitors in Metastastic Adenoid Cystic CarcinomaRecruitingNCT04974866Phase 2
• Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR TrialRecruitingNCT04883671Not applicable
• Adenoid Cystic Carcinoma and Carbon Ion Only IrradiationRecruitingNCT04214366Phase 2
• VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaRecruitingNCT03556228Phase 1/2
• Randomized Carbon Ions vs Standard Radiotherapy for Radioresistant TumorsRecruitingNCT02838602Not applicable
• Amivantamab in Adenoid Cystic CarcinomaActive, not recruitingNCT05074940Phase 2Results posted
• 9-ING-41 Plus Carboplatin in Salivary Gland CarcinomaActive, not recruitingNCT05010629Phase 2Results posted
• MC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland CancerActive, not recruitingNCT04895735Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC)TerminatedNCT04119453Phase 2Results posted
• A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic CarcinomaCompletedNCT03999684Phase 2Results posted
• Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic CarcinomaCompletedNCT03990571Phase 2Results posted
• A Study Of AL101In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch MutationsCompletedNCT03691207Phase 2Results posted
• Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological MalignanciesTerminatedNCT03422679Phase 1/2Results posted
• Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic CarcinomaCompletedNCT03087019Phase 2Results posted
• Compassionate Use of Brontictuzumab for Adenoid Cystic Carcinoma (ACC)CompletedNCT02662608Not applicableResults posted
• Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation TherapyCompletedNCT02123511Phase 2Results posted
• Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic CarcinomaCompletedNCT02098538Phase 2Results posted
• 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyCompletedNCT01806675Phase 1/2Results posted
• Akt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst CarcinomaCompletedNCT01604772Phase 2Results posted
• Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic CarcinomaCompletedNCT01558661Phase 2Results posted
• Study of Dovitinib (TKI258) in Adenoid Cystic CarcinomaCompletedNCT01524692Phase 2Results posted
• Study of Everolimus (RAD001) in Combination With LenalidomideCompletedNCT01218555Phase 1Results posted
• Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic CarcinomaCompletedNCT01175980Phase 2Results posted
• Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and NeckCompletedNCT01065844Phase 2Results posted
• Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland TumorsCompletedNCT00859937Phase 2Results posted
• Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and NeckCompletedNCT00581360Phase 2Results posted
• Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerCompletedNCT00492089Phase 2Results posted
• Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland CancersCompletedNCT00095563Phase 2Results posted
• Surgical Strategy for Head and Neck Adenoid Cystic CancerCompletedNCT06778915
• Agnostic Therapy in Rare Solid TumorsActive, not recruitingNCT06638931Phase 2
• Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILECompletedNCT06535997
• An Investigational Scan (Ga-68 PSMA-11 PET/CT) for the Detection of Therapy Response in Patients With Metastatic Adenoid Cystic CarcinomaCompletedNCT06521775Phase 2
• Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)Active, not recruitingNCT06462183Phase 1
• 177Lu-PSMA (177Lu-PNT2002) in PSMA-Positive Adenoid Cystic CarcinomaTerminatedNCT06322576Phase 2
• The Evaluation of the Effectiveness, Safety and Tolerability of Treatment, Using a PSMA-Lu177, in Patients with ACC- an Open, Non-commercial Clinical TrialWithdrawnNCT06199453Phase 2
• Study of OBT076 Associated or Not in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and NeckTerminatedNCT05930951Phase 1
• PSMA-PET Imaging of Salivary Gland Tumours and Other Rare CancersCompletedNCT05581979
• 68Ga-FAPI PET/CT for the Detection of Adenoid Cystic Carcinoma(ACC)Status unknownNCT05499936Not applicable
• A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid TumorsTerminatedNCT05194072Phase 1
• AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic CancerCompletedNCT04973683Phase 1
• 9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland CarcinomaWithdrawnNCT04832438Phase 2
• Diagnosis of Adenoid Cystic Carcinoma on 68Ga-PSMA-617 PET-CT and Therapy With 177Lu-EB-PSMA-617Status unknownNCT04801264Early Phase 1
• Understanding the Burden of ACC Through the Eyes of PatientsCompletedNCT04706845
• All-trans Retinoic Acid (ATRA) in the Treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and NeckStatus unknownNCT04433169Phase 2
• Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer PatientsCompletedNCT04291300Phase 2
• P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)TerminatedNCT04249947Phase 1
• Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland CancersActive, not recruitingNCT04209660Phase 2
• Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCActive, not recruitingNCT04140526Phase 1/2
• The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT04028479
• A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic MalignanciesCompletedNCT03886831Phase 1
• APG-115 in Salivary Gland Cancer TrialActive, not recruitingNCT03781986Phase 1/2
• Chidamide Combined With Cisplatin in Head and Neck Adenoid Cystic Carcinoma (HNACC)CompletedNCT03639168Phase 2
• PSMA-PET Imaging for Advanced ACC/SDCCompletedNCT03319641Not applicable
• Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACCStatus unknownNCT03291002Phase 1
• MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies TrialCompletedNCT03287427Phase 1
• Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic CarcinomaStatus unknownNCT02942693Phase 2
• Chidamide for Advanced Cephalic and Cervical Adenocystic Carcinoma: Evaluation of Efficiency and SafetyStatus unknownNCT02883374Phase 2
• Lenvatinib in Recurrent and/or Metastatic Adenoid Cystic Carcinomas of the Salivary Glands: ACC-LEN14CompletedNCT02860936Phase 2
• Study of Axitinib in Patients With Recurred or Metastatic Adenoid Cystic CarcinomaCompletedNCT02859012Phase 2
• Nivolumab and Ipilimumab in Treating Patients With Rare TumorsActive, not recruitingNCT02834013Phase 2
• Testing Lenvatinib in Patients With Adenoid Cystic CarcinomaActive, not recruitingNCT02780310Phase 2
• A Study of Apatinib in Recurrent/Metastatic Adenoid Cystic Carcinoma of the Head and NeckStatus unknownNCT02775370Phase 2
• A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary GlandsCompletedNCT01678105Phase 2
• Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck CancerCompletedNCT01637194Phase 1
• Intensity-Modulated or Proton Radiation Therapy for Sinonasal MalignancyActive, not recruitingNCT01586767Not applicable
• Dovitinib in Adenoid Cystic CarcinomaCompletedNCT01417143Phase 2
• Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck CancerTerminatedNCT01254734Not applicable
• Adenoid Cystic Carcinoma, Erbitux, and Particle TherapyStatus unknownNCT01192087Phase 1/2
• Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or ChemotherapyTerminatedNCT01164566Not applicable
• L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck CancerCompletedNCT01155609Not applicable
• Study of RAD001 in Adenoid Cystic CarcinomaCompletedNCT01152840Phase 2
• Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib MesylateCompletedNCT01046487Phase 1
• A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary GlandsCompletedNCT00886132Phase 2
• Photodynamic Therapy Using HPPH in Treating Patients Undergoing Surgery for Primary or Recurrent Head and Neck CancerCompletedNCT00470496Phase 1
• Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
• Study of Imatinib (Glivec) in Patients With Adenoid Cystic Carcinoma of the Head and NeckStatus unknownNCT00180921Phase 2
• Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung CancerCompletedNCT00101348Phase 1/2
• Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNCT00089362Phase 1
• Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and NeckCompletedNCT00077428Phase 2
• Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung CancerCompletedNCT00068497Not applicable
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)CompletedNCT00031681Phase 1
• Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
• Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck CancerCompletedNCT00023959Phase 1

← Carcinoma, Adenoid Cystic overview